Published Date: 22 June 2015 No. of pages : 136

Global Anti-Inflammatory Therapeutics

Market

Inflammation is triggered by the defense system of the body in response to harmful stimuli, damaged cells, irritants and microorganisms. Inflammation is the mechanism of innate immunity, which seeks to eliminate the cause of injury, clear dead and necrotic cells and heal injured tissues. Sometimes, the body defense system inappropriately triggers inflammation against its own cells, resulting in incurable inflammatory autoimmune diseases such as arthritis, asthma and chronic obstructive pulmonary disease (COPD). According to World Health Organization (WHO), approximately 235 million people suffer from asthma in the world. Symptomatic relief during the inflammation provides relief to the patients suffering from inflammatory autoimmune diseases

The global anti-inflammatory therapeutics market is expected to grow at a CAGR of 5.9% over the forecast period, owing to the emergence of anti-inflammatory biologics that are more targeted, effective and with lesser side effects as compared to conventional drugs. In addition, they are also difficult to imitate due to their complex molecular structure and origin. The global anti-inflammatory market has been driven by factors such as increasing autoimmune and respiratory conditions, new drugs in pipeline and increasing adoption of anti-inflammatory drugs. Moreover, increasing awareness of anti-inflammatory therapeutics and attractive government initiatives in the Asia-Pacific and LAMEA region are expected to drive the market during the analysis period.

Introduction to Global Anti-inflammatory Therapeutics Market

Introduction

Scope of the ReportKey Benefits

Key Audiences

KEY BENEFITS

The report provides a quantitative analysis of the current market and estimations during 2014 - 2020 that assist in identifying the prevailing market opportunities to capitalize.

Competitive intelligence (of leading manufacturers and distributors of anti-inflammatory therapeutics) helps in understanding the competitive scenario across the geographies.

Comprehensive analysis of factors that drive and restrict the growth of the global anti-inflammatory therapeutics market is provided.

SWOT analysis enables to study the internal environment of the leading companies for strategy formulation.

The Country level analysis of anti-inflammatory therapeutics market conditions has been provided in this report.

Table of Contents

1. Introduction

2. Executive Summary

3. Market Overview

4. Global Anti-inflammatory Therapeutics Market By Indication

5. Global Anti-inflammatory Therapeutics Market By Drug Class

6. Global Anti-inflammatory Therapeutics Market By Geography

7. Company Profiles

Global Anti-inflammatory Therapeutics Market Overview

1. Report Description

2. CXO Perspective

3. Market Definition and Scope

4. Key Findings

5. Porter‘s Five Force Analysis

6. Market Share Analysis, 2014

7. Market Dynamics

8. Anti-inflammatory Biologics

Global Anti-inflammatory Therapeutics Market By Segments

Global Anti-inflammatory Therapeutics Market By

Indication

• Arthritis• Respiratory diseases• Multiple sclerosis• Psoriasis

Anti-inflammatory Therapeutics

Market Drug Class

• Anti-inflammatory Biologics

• Non-Steroidal Anti-inflammatory drugs (NSAIDs)

• Corticosteroids

Global Anti-inflammatory Therapeutics Market, By Geography

North America, Europe, Asia Pacific, LAMEA

Company Profiles

1. Pfizer Inc.

2. AbbVie Inc.

3. Johnson & Johnson

4. GlaxoSmithKline plc

5. Merck & Co., Inc.

6. Novartis AG

7. F. Hoffmann-La Roche AG

8. Eli Lily and Company

9. AstraZeneca PLC.

10. Amgen Inc.

Follow Us On

Thank You!For More Details

Visit us at

https://www.alliedmarketresearch.com/anti-inflammatory-therapeutics-market